Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Virtuos is a cellular bone allograft developed by Orthofix for use in spinal fusion procedures, such as those treating degenerative disc disease. It is a Human Cells, Tissues, and Cellular and Tissue-Based Product (HCT/P) that provides a complete solution for bone repair by supplying an osteoconductive matrix, osteoinductive growth factors, and osteogenic live cells. Virtuos is unique in being a lyophilized (shelf-stable) cellular bone allograft, which simplifies storage and handling compared to traditional cryopreserved cellular grafts. It is specifically processed to ensure cell viability while minimizing immunogenicity, aiming to achieve high fusion rates in lumbar and cervical spine surgeries by facilitating the natural bone healing process.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Virtuos.